Lori Passmore, Group Leader in the LMB’s Structural Studies Division, chats to The FEBS Journal about her research career to date, including the technological advancements with electron cryo-microscopy, her favourite finding so far, and what advice she would give to early career scientists. More…
Lori Passmore on her research career so far, the benefits of collaboration, and her greatest achievement away from the lab
Andrew Carter on dynein discoveries, his career so far, and pursuits away from research
Following his award of the Hooke Medal from the British Society of Cell Biology, Andrew Carter, Group Leader in the LMB’s Structural Studies Division, has been interviewed by the Journal of Cell Science, covering his early career, his breakthroughs in dynein research and his approach to leading a research group. More…
Lalita Ramakrishnan’s approach to tuberculosis research
To mark World TB Day, Lalita Ramakrishnan, Group Leader in the LMB’s Cell Biology Division and the University of Cambridge’s Molecular Immunity Unit (housed at the LMB), discusses her career journey, the inspiration behind many of her key tuberculosis findings, and her approach to mentoring in the lab. More…
Complex map of fly brain reveals neurological insights
Marta Zlatic and Albert Cardona’s groups in the LMB’s Neurobiology Division (also at the University of Cambridge) have unveiled the first complete map of a fruit fly brain, including all its neurons and connecting synapses. This connectome offers new insights into the brain and will serve as a reference brain, allowing researching to study neurological diseases in greater detail. More…
Kate McDole on developing smart microscopes
Kate McDole, Group Leader in the LMB’s Cell Biology Division, discusses how she has developed an adaptive microscope to track cell movement in mice embryos, including design considerations to control factors including specimen movement, angle of light source and positions of optical elements. More…
Heartburn drug could be effective TB treatment
New research from Lalita Ramakrishnan’s group, in the LMB’s Cell Biology Division and the University of Cambridge’s Molecular Immunity Unit (housed at the LMB), has shown that drugs commonly used to treat heartburn could shorten treatment time of tuberculosis (TB), as well as reduce the likelihood of TB bacteria becoming drug resistant. More…